Patent ID: 11912700
Assignee: PHEON THERAPEUTICS LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 9:
10. The compound of claim 1, wherein the compound is of formula (XIX):, or a pharmaceutically acceptable salt thereof,
wherein:
(i) R5 is H; and
R6 is OH, OCH3, or OCH2CH3; or

(ii) R5 and R6, taken together with the N atom and C atom to which they are attached, form N═C;
L is —C1-8 alkylene-;
R22 is (CH2)jC(O)OR11, (CH2)jNR11R12, or C(O)NHR24;
R11 is H, CH3, CH2CH3, CH2CH2CH3, CH(CH3)2, CH2CH2CH2CH3, CH(CH3)CH2CH3, CH2CH(CH3)2, or C(CH3)3;
R12 is H, CH3, CH2CH3, CH2CH2CH3, CH(CH3)2, CH2CH2CH2CH3, CH(CH3)CH2CH3, CH2CH(CH3)2, or C(CH3)3;
R24 is phenyl, wherein the phenyl is substituted with 1 (CH2)jR18 substituent; and
j is 0, 1, 2, or 3.